A momentous cultural and economic change is soon coming to Canada, as the Canadian Government has committed to legalizing recreational marijuana on July 1, 2018.
Articles
Innovation Drives Value for Leading Cannabis Biotechs
As an increasing volume of scientific research leans toward the efficacy of cannabis-based drugs, innovative biotech companies are advancing their R&D to develop therapeutic candidates that envelop the potential health benefits of the marijuana plant.
Skinvisible, Inc. (SKVI) Develops Hemp-based Products with an Enhanced Delivery System
Skinvisible, Inc.’s proprietary topical drug delivery technology, Invisicare®, improves the delivery of pharmaceutical and medicinal compounds to and through the skin.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Presenting at Cannabis-Based Science & Medicine Conference
InMed Pharmaceuticals this morning said that it will be presenting twice at the Biopharma Forum on ‘Cannabis-Based Science & Medicine’ conference.
Medical Cannabis Payment Solutions is “One to Watch”
Medical Cannabis Payment Solutions (OTC: REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry.
Coming Cannabis Recreational Demand in Canada Triggers Massive Investment
The Canadian government’s commitment to legalize recreational cannabis in July 2018 is touted as an opportunity for investors to profit from the ongoing green blitz.
Marijuana Company of America, Inc. (MCOA) Builds Momentum as Legalization Push Gains Steam
Marijuana Company of America (OTC: MCOA) is strongly positioned as the cannabis market continues to relentlessly expand throughout the country. In an effort to keep up with the increasing demand, the company entered an agreement with Bougainville Ventures to build a new structure.
Copy of Marijuana Company of America, Inc. (MCOA) Offers Portfolio of Promise in Cannabis and Hemp
With a portfolio of operating subsidiaries, partnerships and joint ventures, Marijuana Company of America (OTC: MCOA) offers investors broad diversification guided by experienced and savvy management.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Driving Cannabis Costs Down While Meeting Patient Needs
Abcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), a manufacturer and distributor of medical cannabis in Canada, is creating a consistent, organically grown, pesticide-free standardized product that is keeping costs down and investors excited.
Biosynthesis: Making the Impossible Possible in Medicinal Cannabis
InMed Pharmaceuticals, Inc. has broken new ground with an innovative, proprietary biosynthesis process that reliably creates pure cannabinoids.
Medical Cannabis Payment Solutions (REFG) Offers Cannabis Retailers Merchant Processing They Can Bank On
Through its wholly owned subsidiary, StateSourced, the company provides a proprietary, closed loop system of merchant processing for marijuana enterprises.
Meteoric Rise of Bitcoin, Open Embracing of Blockchain by Sector Majors
The price of bitcoin recently hit an all-time high of more than $7,800, edging closer to Goldman Sachs’ (NYSE: GS) forecast that the cryptocurrency will hit $8,000.
Why Medical Cannabis Payment Solutions (REFG) is “One to Watch”
Medical Cannabis Payment Solutions is intent on opening the bottleneck with its proprietary merchant processing system designed to serve the monetary demands of the state-legalized cannabis market.
Cannabis Biotechs Could be Big Pharma’s Latest M&A Focus
InMed’s promising biosynthesis platform could put it on the radar of some major names seeking entry into one the pharmaceutical industry’s fastest-growing sectors.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Boosts Revenue by Out-Licensing Patented Technology to Third-Party Partners
Lexaria generates revenue by out-licensing its patented global technology related to ingestion of edible cannabinoids at a rate of 5-10% of gross sales to its third-party partners.